CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

MIDD Paired Meeting Program Frequently Asked Questions

Neutral
AI Analysis

Summary

This is a frequently asked questions document about the FDA's MIDD (Molecular Imaging and Diagnostic Devices) Paired Meeting Program pilot initiative. No specific drug candidates, companies, or material clinical or regulatory events are discussed.

Importance:1/10
Sentiment:
0.00
FDAregulatoryguidance

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 25, 2026 1:45 PM

Read Original